# Evaluation of the Efficacy of Intra-nasal Sufentanil for Analgesia of Vaso-occlusive Crisis in Sickle-cell Adults.

> **NCT04076748** · PHASE3 · UNKNOWN · sponsor: **University Hospital, Bordeaux** · enrollment: 196 (estimated)

## Conditions studied

- Sickle Cell Crisis

## Interventions

- **DRUG:** Sufentanil
- **DRUG:** EMONO

## Key facts

- **NCT ID:** NCT04076748
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-20
- **Primary completion:** 2024-01
- **Final completion:** 2024-01
- **Target enrollment:** 196 (ESTIMATED)
- **Last updated:** 2023-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04076748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04076748, "Evaluation of the Efficacy of Intra-nasal Sufentanil for Analgesia of Vaso-occlusive Crisis in Sickle-cell Adults.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04076748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*